Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Yidan Ren"'
Publikováno v:
Heliyon, Vol 10, Iss 7, Pp e27739- (2024)
Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of chronic liver disease, with a range of conditions including non-alcoholic fatty liver, non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Currently rec
Externí odkaz:
https://doaj.org/article/b3fbec3f5dd64b3d9e2170a10aa925e5
Autor:
Lin Xia, Maoxiao Feng, Yidan Ren, Xiaodong Hao, Qinlian Jiao, QinChen Xu, Yunshan Wang, Qin Wang, Ningji Gong
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract Dermatan sulfate epimerase (DSE) is a C5 epiminase that plays a key role in converting chondroitin sulfate into dermal sulfate. DSE is often upregulated during carcinogenesis of some types of cancer and can regulate growth factor signaling i
Externí odkaz:
https://doaj.org/article/3eed86acbf59419ab2d0312268aa78d9
Autor:
Qinchen Xu, Maoxiao Feng, Yidan Ren, Xiaoyan Liu, Huiru Gao, Zigan Li, Xin Su, Qin Wang, Yunshan Wang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 165, Iss , Pp 115028- (2023)
Non-alcoholic fatty liver disease (NAFLD) has gradually become one of the major liver health problems in the world. The dynamic course of the disease goes through steatosis, inflammation, fibrosis, and carcinoma. Before progressing to carcinoma, time
Externí odkaz:
https://doaj.org/article/0bbd3a150dc74a49b0f8fa7ced200a5e
Autor:
Peilong Li, Xueying Shang, Qinlian Jiao, Qi Mi, Mengqian Zhu, Yidan Ren, Juan Li, Li Li, Jin Liu, Chuanxin Wang, Yi Shi, Yunshan Wang, Lutao Du
Publikováno v:
Exploration, Vol 3, Iss 4, Pp n/a-n/a (2023)
Abstract Oxaliplatin is a first‐line chemotherapy drug widely adopted in colorectal cancer (CRC) treatment. However, a large proportion of patients tend to become resistant to oxaliplatin, causing chemotherapy to fail. At present, researches on oxa
Externí odkaz:
https://doaj.org/article/572a575a47be4ca0984c353181e591e1
Autor:
QinChen Xu, Xiaoyan Liu, Ghazal Mohseni, Xiaodong Hao, Yidan Ren, Yiwei Xu, Huiru Gao, Qin Wang, Yunshan Wang
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-21 (2022)
Abstract Nicotinamide adenine dinucleotide (NAD) is the core of cellular energy metabolism. NAMPT, Sirtuins, PARP, CD38, and other molecules in this classic metabolic pathway affect many key cellular functions and are closely related to the occurrenc
Externí odkaz:
https://doaj.org/article/edb845d4e29d4760bed9805b96f356f0
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/95d747cb6b7c4e15a4c8abee241a3086
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Tumors meet their energy, biosynthesis, and redox demands through metabolic reprogramming. This metabolic abnormality results in elevated levels of metabolites, particularly lactate, in the tumor microenvironment. Immune cell reprogramming and cellul
Externí odkaz:
https://doaj.org/article/a3525c014b09442eadb9d16b7cad4d1f
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 141, Iss , Pp 111798- (2021)
Hypoxia is a common phenomenon in most malignant tumors, especially in pancreatic cancer (PC). Hypoxia is the result of unlimited tumor growth and plays an active role in promoting tumor survival, progression, and invasion. As the part of the hypoxia
Externí odkaz:
https://doaj.org/article/1d9f37a6a5934555887e4dc4823a729a
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-14 (2019)
Abstract Background Chronic obstructive pulmonary disease (COPD) is a common respiratory disease with high morbidity and mortality. The most important pathophysiological change of COPD is airway obstruction. Airway obstruction can cause airflow restr
Externí odkaz:
https://doaj.org/article/fdd71c2b72e54022985a5e9faa2b048f
Autor:
Ce Li, Lutao Du, Yidan Ren, Xiaoyan Liu, Qinlian Jiao, Donghai Cui, Mingxin Wen, Chuanxin Wang, Guangwei Wei, Yunshan Wang, Aiguo Ji, Qin Wang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-15 (2019)
Abstract Background S-phase kinase-associated protein 2 (SKP2) is an oncogene and cell cycle regulator that specifically recognizes phosphorylated cell cycle regulator proteins and mediates their ubiquitination. Programmed cell death protein 4 (PDCD4
Externí odkaz:
https://doaj.org/article/cc3fbff61946460189ca078f66a414a4